首页> 美国卫生研究院文献>Science Advances >Near-infrared upconversion–activated CRISPR-Cas9 system: A remote-controlled gene editing platform
【2h】

Near-infrared upconversion–activated CRISPR-Cas9 system: A remote-controlled gene editing platform

机译:近红外上转换激活的CRISPR-Cas9系统:远程控制的基因编辑平台

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

As an RNA-guided nuclease, CRISPR-Cas9 offers facile and promising solutions to mediate genome modification with respect to versatility and high precision. However, spatiotemporal manipulation of CRISPR-Cas9 delivery remains a daunting challenge for robust effectuation of gene editing both in vitro and in vivo. Here, we designed a near-infrared (NIR) light–responsive nanocarrier of CRISPR-Cas9 for cancer therapeutics based on upconversion nanoparticles (UCNPs). The UCNPs served as “nanotransducers” that can convert NIR light (980 nm) into local ultraviolet light for the cleavage of photosensitive molecules, thereby resulting in on-demand release of CRISPR-Cas9. In addition, by preparing a single guide RNA targeting a tumor gene (polo-like kinase-1), our strategies have successfully inhibited the proliferation of tumor cell via NIR light–activated gene editing both in vitro and in vivo. Overall, this exogenously controlled method presents enormous potential for targeted gene editing in deep tissues and treatment of a myriad of diseases.
机译:作为RNA引导的核酸酶,CRISPR-Cas9提供了灵活而有前途的解决方案,可在通用性和高精度方面介导基因组修饰。然而,对于在体外和体内有效实现基因编辑而言,CRISPR-Cas9传递的时空操纵仍然是一项艰巨的挑战。在这里,我们基于上转换纳米粒子(UCNPs)设计了CRISPR-Cas9的近红外(NIR)光响应纳米载体,用于癌症治疗。 UCNP充当“纳米换能器”,可以将NIR光(980 nm)转换成局部紫外光,以裂解光敏分子,从而按需释放CRISPR-Cas9。此外,通过制备靶向肿瘤基因(polo样激酶-1)的单个指导RNA,我们的策略通过在体内外进行NIR光激活基因编辑成功地抑制了肿瘤细胞的增殖。总体而言,这种外源控制的方法为深部组织中的靶向基因编辑和多种疾病的治疗提供了巨大的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号